Location History:
- Menlo Park, CA (US) (1993 - 1994)
- Galveston, TX (US) (2003)
Company Filing History:
2 out of 83 
1 out of 832,812 Years Active: 1993-2003
Title: Innovations by Steven L Young
Introduction
Steven L Young is an accomplished inventor based in Menlo Park, CA. He holds a total of 3 patents that reflect his contributions to medical and biochemical advancements. His work focuses on non-invasive treatments and innovative methods for enzyme activity determination.
Latest Patents
One of his latest patents is titled "Compositions and methods for the non-invasive treatment of uterine fibroid cells." This invention addresses the proliferation of uterine fibroid leiomyoma cells by utilizing specific Fibroid Cell Growth Inhibitor (FGI) agents. These agents can inhibit cell growth and induce cell death without the disadvantages of surgical or systemic hormonal therapies. The delivery methods for these agents are designed to be non-invasive, utilizing techniques such as intra-vaginal and in situ injections. Another significant patent involves "Fluorescent chloramphenicol derivatives for determination of chloramphenicol acetyltransferase (CAT) enzyme activity." This patent describes fluorescent compounds that can be used to measure CAT enzyme activity through the production of fluorescent mono- and diacylated products.
Career Highlights
Throughout his career, Steven has worked with notable companies, including Molecular Probes, Inc. His innovative approaches have led to significant advancements in the fields of medicine and biochemistry.
Collaborations
Steven has collaborated with esteemed colleagues such as Hee Chol Kang and Michael H Melner, contributing to the success of his projects and patents.
Conclusion
Steven L Young's work exemplifies the spirit of innovation in the medical field, particularly through his non-invasive treatment methods and enzyme activity determination techniques. His contributions continue to impact the industry positively.